Trials / Completed
CompletedNCT00641264
Quality of Life Validation in Laryngitis
Laryngopharyngeal Reflux Health Related Quality of Life (LPR-HRQL) Questionnaire Development and Psychometric Testing in Patients Receiving Omeprazole 20 mg Bid as Treatment for Laryngopharyngeal Reflux.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study was to establish the psychometric properties of a new disease specific Quality of Life questionnaire, the LPR-HRQL. The specific properties of the questionnaire that were evaluated were: validity, reliability, and responsiveness to change (as a measure of treatment effect).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omeprazole | |
| BEHAVIORAL | Quality of Life questionnaire |
Timeline
- Start date
- 2001-05-01
- Primary completion
- 2003-06-01
- Completion
- 2003-06-01
- First posted
- 2008-03-24
- Last updated
- 2009-06-11
Source: ClinicalTrials.gov record NCT00641264. Inclusion in this directory is not an endorsement.